OMH SCIENCE Group Co., Ltd (SHE:300486)

CTI BioPharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	385.87	456.97	586.07	671.21	331.9	274.85
Trading Asset Securities	20.37	20.37	20.29	100.44	0.33	0.25
Cash & Short-Term Investments	406.25	477.34	606.36	771.65	332.23	275.1
Cash Growth	-18.10%	-21.28%	-21.42%	132.27%	20.77%	-10.72%
Accounts Receivable	809.95	812.35	808.28	983.81	930.32	907.88
Other Receivables	123.73	25.93	30.02	43.03	67.54	29.16
Receivables	933.68	838.28	838.3	1,027	997.86	937.04
Inventory	278.77	365.91	546.97	283.75	255.74	399.93
Other Current Assets	119.83	111.33	111.86	110.68	94.38	64.71
Total Current Assets	1,739	1,793	2,103	2,193	1,680	1,677
Property, Plant & Equipment	747.38	749.79	747.78	716.95	682.02	652.53
Long-Term Investments	63	63	65.12	72.3	97.97	118.29
Goodwill	161.29	161.29	221.96	288.83	288.83	299.96
Other Intangible Assets	100.69	102.21	103.45	108.06	112.63	133.38
Long-Term Deferred Tax Assets	104.57	105.17	64.55	27.82	21.15	18.53
Long-Term Deferred Charges	20.19	18.52	10.52	14.41	4.99	10.93
Other Long-Term Assets	25.52	28.96	42.84	54.07	44.4	76.43
Total Assets	2,961	3,022	3,360	3,475	2,932	2,987
Accounts Payable	518.49	594.24	789.64	607.58	542.28	517.51
Accrued Expenses	11.02	31.68	36.93	65.79	45.82	39.86
Short-Term Debt	339.24	285.34	197.04	201.4	277.23	280.41
Current Portion of Long-Term Debt	15.76	57.75	26.72	12.68	12.08	9.67
Current Portion of Leases	-	9.21	36.47	49.67	48.73	19.95
Current Income Taxes Payable	3.87	-	1.29	8.68	11.89	13.38
Current Unearned Revenue	104.2	156.45	170.33	204.91	284.19	349.37
Other Current Liabilities	77.04	85.29	66.13	48.19	44.57	75.51
Total Current Liabilities	1,070	1,220	1,325	1,199	1,267	1,306
Long-Term Debt	676.63	610.25	583.54	532.93	35.7	101.18
Long-Term Leases	20.05	1.13	10.06	48.03	52.71	1.6
Long-Term Unearned Revenue	46.56	46.9	41.87	42.17	41.76	42.09
Long-Term Deferred Tax Liabilities	0.54	0.6	0.85	1.11	1.36	5.14
Other Long-Term Liabilities	-	-	0.34	-	-	-
Total Liabilities	1,813	1,879	1,961	1,823	1,398	1,456
Common Stock	407.65	407.65	407.43	406.51	406.51	271.01
Additional Paid-In Capital	619.95	619.95	618.39	612.02	609.95	748.92
Retained Earnings	57.93	53.8	311.07	564.38	527.41	471.08
Comprehensive Income & Other	60.83	60.15	60.2	67.79	-11.4	-6.11
Total Common Equity	1,146	1,142	1,397	1,651	1,532	1,485
Minority Interest	1.41	1.41	1.42	1.53	1.4	46.27
Shareholders' Equity	1,148	1,143	1,399	1,652	1,534	1,531
Total Liabilities & Equity	2,961	3,022	3,360	3,475	2,932	2,987
Total Debt	1,052	963.68	853.84	844.71	426.46	412.81
Net Cash (Debt)	-645.43	-486.34	-247.47	-73.05	-94.24	-137.71
Net Cash Per Share	-1.50	-1.19	-0.61	-0.18	-0.24	-0.33
Filing Date Shares Outstanding	407.65	407.65	407.43	406.51	406.51	406.51
Total Common Shares Outstanding	407.65	407.65	407.43	406.51	406.51	406.51
Working Capital	668.92	572.91	778.95	994.01	413.42	371.13
Book Value Per Share	2.81	2.80	3.43	4.06	3.77	3.65
Tangible Book Value	884.38	878.05	1,072	1,254	1,131	1,052
Tangible Book Value Per Share	2.17	2.15	2.63	3.08	2.78	2.59
Buildings	-	457.43	269.05	183.53	155.32	264.04
Machinery	-	440.85	482.92	427.06	384.01	305.63
Construction In Progress	-	72.33	195.45	287.9	298.09	236.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.